KMVAX Performance — Kirr, Marbach Partners Value Fund
Data updated: 2026-08-28
KMVAX returned +15.39% year to date and +18.50% over one year to Jun 2026. Annualised returns are +21.20% over 3 years and +13.78% over 5 years. The fund beat its US Mid-Cap Growth category average: $100 invested three years ago grew to $178, against $152 for the category, and to $119 over one year, against $118. Volatility over the past three years was 15.76% a year. In the 12 months to Jun 2026 the fund took in a net $1.5M, and assets reached $115.65M.
KMVAX Growth of $100
What $100 invested in Kirr, Marbach Partners Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | KMVAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $119 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $178 | $152 |
| 5 years (Jul 2021 – Jun 2026) | $191 | $129 |
| Since data start (Jan 2020 – Jun 2026) | $227 | $193 |
KMVAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +15.39% |
| 1 year | +18.50% |
| 3 years (annualised) | +21.20% |
| 5 years (annualised) | +13.78% |
KMVAX Annual Returns
Calendar-year total returns of Kirr, Marbach Partners Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +15.39% |
| 2025 | +14.37% |
| 2024 | +27.91% |
| 2023 | +20.39% |
| 2022 | −15.98% |
| 2021 | +28.84% |
| 2020 | +2.97% |
KMVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.6% | +4.2% | −5.6% | +11.2% | +0.3% | +1.5% | — | — | — | — | — | — |
| 2025 | +4.6% | −4.3% | −6.0% | +2.3% | +9.5% | +5.8% | +4.7% | +2.0% | +0.8% | −2.0% | +0.1% | −2.8% |
| 2024 | +0.3% | +7.2% | +6.0% | −4.1% | +5.6% | +0.2% | +4.0% | +0.4% | +3.3% | −1.7% | +8.1% | −3.4% |
| 2023 | +8.8% | −1.8% | −0.2% | +1.9% | −2.0% | +7.1% | +3.0% | −1.4% | −5.7% | −3.8% | +7.3% | +6.7% |
| 2022 | −6.1% | −1.3% | +3.0% | −8.9% | +0.6% | −7.3% | +8.5% | −5.8% | −8.6% | +8.9% | +7.4% | −5.2% |
| 2021 | −0.7% | +4.1% | +6.8% | +4.0% | +1.0% | −0.4% | +2.9% | +2.0% | −4.3% | +8.7% | −3.5% | +6.0% |
| 2020 | −3.1% | −9.0% | −24.2% | +13.3% | +6.5% | +0.7% | +3.5% | +5.3% | −4.5% | +0.5% | +15.4% | +5.0% |
KMVAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.76%
- 3-year Sharpe ratio: 1.06 (vs 4.5% risk-free rate)
- Best month: +11.18% (Apr 2026)
- Worst month: −6.04% (Mar 2025)
KMVAX Fund Flows
Monthly money in and out of Kirr, Marbach Partners Value Fund, from SEC Form N-PORT.
- 12-month net flow: $1.5M
- 12-month gross sales (incl. reinvestments): $23.2M
- Sales ÷ redemptions: 1.07×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $419K | $470K | −$51K |
| May 2026 | $347K | $1.3M | −$1000K |
| Apr 2026 | $158K | $952K | −$794K |
| Mar 2026 | $221K | $411K | −$190K |
| Feb 2026 | $1.6M | $234K | $1.4M |
| Jan 2026 | $662K | $10.3M | −$9.6M |
| Dec 2025 | $6.0M | $1.7M | $4.3M |
| Nov 2025 | $460K | $503K | −$44K |
| Oct 2025 | $9.7M | $1.5M | $8.1M |
| Sep 2025 | $1.1M | $915K | $135K |
| Aug 2025 | $2.0M | $705K | $1.3M |
| Jul 2025 | $553K | $2.6M | −$2.0M |
KMVAX Assets Under Management
Net assets of Kirr, Marbach Partners Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $115.65M |
| 2026-03-31 | $103.85M |
| 2025-12-31 | $110.08M |
| 2025-09-30 | $108.57M |
| 2025-06-30 | $101.56M |
| 2025-03-31 | $85.56M |
| 2024-12-31 | $91.17M |
| 2024-09-30 | $90.13M |
| 2024-06-30 | $84.72M |
| 2024-03-31 | $84.60M |
| 2023-12-31 | $75.18M |
| 2023-09-30 | $68.43M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.